Saturday, June 9, 2007

Update on Venous Thrombosis and IVC Filters
BCC: Ballroom IV
Moderator:  Robert B. McLafferty, MD
Southern Illinois University School of Medicine, Springfield, Ill.

At the end of this session, participants should be able to:

1. Understand the evidence behind the use of
   pharmacologic thrombolysis for the treatment of acute
   DVT of the lower extremity and translate that into practice guidelines.
2. Obtain new information about how to optimally use of
   mechanical thrombolysis in the treatment of acute DVT.
3. Have a comprehensive understanding of proper patient selection
   using the correct device and selected technique for placing IVC filters.
   
   7:00 am
   Update on Pharmacologic Thrombolysis for Acute DVT:
   Evidence to Practical Recommendations
   Mark Meissner, MD, University of Washington, Seattle, Wash. 

7:12 am
Optimizing Patient, Device, and Technique Selection for
Placement of Inferior Vena Cava Filters
Marc Passman, MD, University of Alabama, Birmingham, Ala.

7:24 am
New Devices and Techniques Using Mechanical
Thrombolysis for Acute DVT
Peter Lin, MD, Baylor University, Houston, Texas

EVAR – The Basics and Beyond
Supported by an educational grant from Cook Medical
BCC: Rooms 309/310
Moderator: Darren B. Schneider, MD
University of California-San Francisco, San Francisco, Calif.

At the end of this session, participants should be able to:

1. Understand patient selection and pre-operative planning for EVAR.
2. Have knowledge of a variety of endovascular techniques
   and strategies to manage difficult anatomy during EVAR.
3. Understand the role of EVAR for the management of ruptured AAA’s.
   
   7:00 am
   Planning For Success – Pre-Operative Imaging Issues
   Edwin Charles Gravereaux, MD,
   Brigham & Women’s Hospital, Boston, Mass.

7:12 am
Overcoming Difficult Iliac Access
Peter H. Lin, MD, Baylor College of Medicine, Houston, Texas

7:24 am
Challenging Neck Anatomy – Too Short, Too Wide, Too Tortuous
W. Anthony Lee, MD,
University of Florida, College of Medicine, Gainesville, Fla.

7:36 am
Emergency EVAR For Ruptured AAA’s
Manish Mehta, MD, The Vascular Group, PLLC, Albany, N.Y.

7:48 am
EVAR: Future Directions
Timothy A.M. Chuter, MD,
University of California - San Francisco, San Francisco, Calif.

8:00 am
Panel Discussion: Questions and Answers

At the end of this session, participants should be able to:

1. Discuss the methodology, results, and conclusions
   of the research presented in vascular health.
2. Gain knowledge of new technology for diagnosis and
   treatment of vascular disease.

8:30 am
S26. Doxycycline Delays Aneurysm Rupture In Marfan Syndrome

8:46 am
S27. Novel Markers of Carotid Plaque Vulnerability

9:02 am
S28. Trends and Outcomes of Thrombolysis for
Deep Venous Thrombosis

9:18 am
S29. Benign Superior Vena Cava Syndrome:
Is Stenting the First Line of Treatment?

9:34 am
S30.  Educating America About Venous Disease:
The American Venous Forum Expands the National
Venous Screening Program

Moderators:
Gregory J. Pearl, MD
Texas Vascular Associates, P.A., Dallas, Texas

TBA

At the end of this session, participants should be able to:

1. Discuss the methodology, results, and conclusions
   of the research presented in vascular health.
2. Gain knowledge of new technology for diagnosis and
   treatment of vascular disease.

10:20am
S31. LATE-BREAKING CLINICAL TRIAL:
Early Results of an International Controlled Trial of TEVAR

10:36 am
S32. Aortic Reconstruction with Femoral-Popliteal Vein:
Graft Stenosis Incidence, Risk and Re-Intervention

10:52 am
S33. Quality of Life of Patients with Takayasu's Arteritis

11:08 am
S34. Common Iliac Artery Aneurysm: Expansion Rate
and Results of Open Surgical and Endovascular Repair

11:24 am
S35. A Population-Level Analysis: The Incidence and
Factors Associated with Aortic Graft Infection

11:40 am
S36. A Regional Registry for Quality Assurance and Improvement:
The Vascular Study Group of Northern New England (VSG-NNE)

Session S1: Clinical Debates
BCC: Rooms 307/308
Moderator: Frank J. Veith, MD
Vascular Surgery Cleveland Clinic Cleveland, Ohio

At the end of this session, participants should be able to:

1. Know the relative roles of endovascular and open surgical bypasses
   in the treatment of TASC C and D superficial femoral occlusive disease.
2. Understand the relative roles of aggressive endovascular and conservative
   therapy in the treatment of lower extremity deep venous thrombosis.
3. Have a good grasp of the expected outcomes of the
   two forms of therapy in the two entities discussed.
   
   1:30 pm
   Optimal Therapy for TASC C/D Superficial Femoral Artery
   Occlusive Disease: Is Bypass Still Preferred?
   Pro: Joseph L. Mills, MD
   Arizona Health Sciences Center, Tucson, Ariz.

Con: Marc L. Schermerhorn, MD
Beth Israel Deaconess Medical Center, Boston, Mass.

2:15 pm
Lower Extremity Deep Venous Thrombosis:
Is an Aggressive Endovascular Approach the Way to Go?
Pro: Frank R. Arko, MD
UT Southwestern Med Center at Dallas, Dallas, Texas

Con: Mark H. Meissner, MD
University of Washington, Seattle, Wash.

Session S2: Branding Your Practice Materials and Session
Sponsored by SVS Communications Committee
BCC: Rooms 309/310
Moderator: Bruce A. Perler, MD
Johns Hopkins University, Baltimore, Md.

At the end of this session, participants should be able to:

Learn how to position your practice as your community’s authority on
vascular health and treatments. This new session features branding
techniques targeted to referring physicians, the media and the public
using materials in a new comprehensive turn-key kit, Branding Your
Practice Toolkit. Attendees will receive information about the toolkit in
their registration packets. A practice management consultant will present
the branding techniques, and SVS members will share their real-life
branding experience.

1:30 pm
Introduction and Overview
Bruce A. Perler, MD, MBA
Johns Hopkins University, Baltimore, Md.

1:40 pm
How to Brand: A Professional Consultant’s Recommendations
Rebecca Anwar, PhD, President, The Sage Group, Philadelphia, Pa.

2:25 pm
How We Do It
George H. Meier, MD
Vascular & Transplant Specialists, PC, Norfolk, Va.

2:45 pm
Edward B. Diethrich, MD
Arizona Heart Institute, Phoenix, Ariz.

Session S3: Peripheral Vascular Surgical Society Paper
BCC: Rooms 318-323
Moderators: 
Mark K. Eskandari, MD
Northwestern University, Feinberg School of Medicine, Chicago, Ill.

John S. Lane, III, MD
University of California – Irvine, Orange, Calif.

At the end of this session, participants should be able to:

1. Understand the choices for imaging of vascular diseases and their limitations.
2. Appreciate the role of open and endovascular procedures for carotid therapy.
3. Review the current status and outcomes of
   treatment for thoracic and abdominal aneurysms.
4. Understand the management options and limitations
   for treatment of lower extremity occlusive disease. 
5. Appraise novel therapies for vascular disease

1:30 pm
PVSS13. Validation of a New, Simple Subclassification of ASA III
Patients Undergoing Peripheral Revascularization Based On Functional Status

1:45 pm  
PVSS14. ePTFE Covered Spiral Nitinol Stents (aSpire) for SFA Disease

2:00 pm
PVSS15. The Medial vs. the Posterior Approach in the Repair
of Popliteal Artery Aneurysms: A Multicenter Case-matched Study

2:15 pm  
PVSS16. Infra-geniculate Interventions for Critical Limb Ischemia
as an Alternative to Surgical Bypass in High Risk Patients

2:30 pm
PVSS17.  Profunda Femoris Artery Aneurysms:
Association with Aneurysmal Disease and Limb Ischemia

2:45 pm
PVSS18. Therapy of Renal Artery Aneurysms in New York State:
Identifying Patients Undergoing Endovascular or Open Repair at
Risk of Death or in Need of Future Supportive Care